This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Ferring B.v., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1999-2026.
Company Filing History:
1 out of 209 
1 out of 3,690 
Years Active: 1999-2026
Title: The Innovations of Todd W Vanderah
Introduction
Todd W Vanderah is a prominent inventor based in Tucson, AZ (US). He is known for his significant contributions to the field of opioid research, particularly in developing peptides that exhibit high selectivity for the kappa opioid receptor (KOR). His work aims to create compounds that provide therapeutic benefits without the adverse effects commonly associated with traditional opioids.
Latest Patents
Todd W Vanderah holds a patent for "Kappa receptor opioid peptides." This patent describes peptides that demonstrate high selectivity for the kappa opioid receptor and possess a long duration of peripheral action without significant entry into the brain. The sequences consist of four D-isomer amino acid residues with a C-terminus that is a mono or di-substituted amide. The representative compounds have an affinity for the KOR that is at least 1,000 times greater than their affinity for the mu opioid receptor, with an ED.sub.50 of not greater than about 0.5 mg/kg.
Career Highlights
Throughout his career, Todd W Vanderah has made notable advancements in opioid research. His innovative approach to developing selective kappa opioid receptor peptides has the potential to revolutionize pain management and addiction treatment. He is currently associated with Ferring B.V., where he continues to explore new therapeutic avenues.
Collaborations
Todd has collaborated with esteemed colleagues such as Jean Louis Junien and Pierre Jm Riviere. Their combined expertise has contributed to the advancement of research in opioid peptides and their applications.
Conclusion
Todd W Vanderah's work in developing kappa receptor opioid peptides represents a significant advancement in the field of pain management. His innovative research continues to pave the way for safer and more effective therapeutic options.